1. Arylacryl amides: Design, synthesis and the protection against cisplatin-induced acute kidney injury via TLR4/STING/NF-κB pathway.
- Author
-
Wu, Xiaoming, Zhou, Long, Li, Ziyun, Rong, Kuanrong, Gao, Shan, Chen, Yun, Zuo, Jiawei, and Tang, Wenjian
- Subjects
- *
ACUTE kidney failure , *CISPLATIN , *AMIDES , *VENOM , *BLOOD urea nitrogen , *STRUCTURE-activity relationships , *EPITHELIAL cells - Abstract
[Display omitted] • An activated ester of HOBt is converted to an ether by intramolecular nucleophilic substitution. • Arylacryl amide 9d protects against cisplatin-induced AKI through inhibiting inflammation via TLR4/STING/NF-κB pathway. • 9d improved renal tubular damage by reducing NF-κB phosphorylation level and promoting tubular epithelial cell proliferation. • 9d reduced the release of inflammatory factors (IL-1β, IL-6 and TNF-α) and the expression of KIM-1 proteins in vivo. Arylpropionic ester scaffold was found as anti-inflammatory agents for the treatment and prevention of acute kidney injury (AKI). To further study the structure–activity relationship (SAR) of this scaffold, a series of acryl amides were designed, synthesized, and evaluated their anti-inflammation. Of these, compound 9d displayed the protective effect on renal tubular epithelial cells to significantly enhance the survival rate through inhibiting NF-κB phosphorylation and promoting cell proliferation in cisplatin-induced HK2 cells. Furthermore, 9d can interact with TLR4 to inhibit TLR4/STING/NF-κB pathway in the RAW264.7 cell. In vivo AKI mice model, 9d significantly downregulated the level of serum creatinine (Scr), blood urea nitrogen (BUN) and the inflammatory factors (IL-1β, IL-6, TNF-α) to improve kidney function. Morphological and KIM-1 analyses showed that 9d alleviated cisplatin-induced tubular damage. In a word, 9d was a promising lead compound for preventive and therapeutic of AKI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF